(Press-News.org) Research published today from Queen Mary University of London reveals less than 1 in 3 women have taken folic acid supplements before pregnancy to prevent spina bifida and other birth defects of the brain, spine, or spinal cord (neural tube defects). This is despite research from 1991 showing that such conditions could be prevented in most cases by increasing the intake of the B-vitamin folic acid before pregnancy.
The study, carried out by Queen Mary's Wolfson Institute of Preventive Medicine and published in the journal PLOS ONE, questioned nearly half a million women attending antenatal screening between 1999 and 2012 in England and the Isle of Man. The proportion of women taking folic acid supplements decreased from 35% in 1999-2001 to 31% in 2011-2012.
The study also showed strong ethnic variations with only 17% of Afro-Caribbean women, 20% of South Asian women and 25% of East Asian women taking folic acid supplements, compared with 35% of Caucasian women. In addition, only 6% of women under 20 were taking folic acid supplements compared with 40% of women aged 35 to 39.
Women who had previously had a pregnancy involving neural tube defects were more likely to take folic acid supplements before pregnancy than women who had not, but still only half of them did (51%) in spite of their high risk of a recurrence.
Additionally, the proportion of women who started taking folic acid supplements after finding out they were pregnant increased from 45% to 62%. However, for the preventive benefits to be effective, folic acid supplements need to be taken before pregnancy.
"Each year in Britain there are about 1,000 pregnancies affected by spina bifida or other birth defects of the brain, spine, or spinal cord. Most of these lead to a termination of pregnancy which is an agonising decision for couples who want a child." said Joan Morris, co-author and Professor of Medical Statistics at Queen Mary.
Over 70 countries, including the US and Australia, have introduced mandatory folic acid fortification to reduce the risk of women having a pregnancy affected with neural tube defects. Despite recommendations from the Food Standards Agency to fortify flour with folic acid, and evidence that folic acid fortification is effective, neither the UK nor any other EU country has mandated this.
"The current UK policy of recommending women take folic acid supplements has failed and has also led to health inequalities among ethnic minorities and younger women. The Government should introduce mandatory fortification of flour with folic acid without delay." said Jonathan Bestwick, lead author and Lecturer in Medical Statistics at Queen Mary.
Professor Sir Nicholas Wald, a co-author from Queen Mary, who conducted the original research showing the protective effect of folic acid said: "It's a public health tragedy that in spite of the folic acid fortification initiative in many countries, the UK has not introduced mandatory folic acid fortification. The failure to fortify flour with folic acid is like having a polio vaccine and not using it."
INFORMATION:
For media information contact:
Charli Scouller
PR Manager (School of Medicine and Dentistry)
Queen Mary University of London
c.scouller@qmul.ac.uk
Tel: 020 7882 7943
Notes to the editor
A link to the full paper will be available here http://dx.plos.org/10.1371/journal.pone.0089354 and PDF copies are available upon request.
This research was carried out by the Wolfson Institute of Preventive Medicine, which is part of Queen Mary University of London, Barts and the London School of Medicine and Dentistry.
About Queen Mary University of London
Queen Mary University of London is one of the UK's leading research-focused higher education institutions with 17,000 undergraduate and postgraduate students.
A member of the Russell Group, QM is amongst the largest of the colleges of the University of London. QM's 4,000 staff deliver world-class degrees and research across 21 academic departments and institutes, within three Faculties: Science and Engineering; Humanities and Social Sciences; and the School of Medicine and Dentistry.
Queen Mary is ranked 11th in the UK according to the Guardian analysis of the 2008 Research Assessment Exercise, and has been described as 'the biggest star among the research-intensive institutions' by the Times Higher Education. In 2012, a Queen Mary study was awarded Research Project of the Year at the Times Higher Education Awards. The university has been nominated again in 2013.
In 2014, Queen Mary was positioned 35th among 130 UK universities in the Complete University Guide and 36th according to the Guardian University Guide. The 2013-4 QS World Rankings placed us 115th of 700 universities worldwide and 19th in the UK, while the 2013 Shanghai Jiao Tong Academic Rankings of World Universities placed us in the top 30 in the UK and in the top 201-300 bracket worldwide.
QM has a strong international reputation, with around 20 per cent of students coming from over 150 countries. The university has an annual turnover of £350m, research income worth £100m, and generates employment and output worth £700m to the UK economy each year.
QM is unique amongst London's universities in being able to offer a completely integrated residential campus, with a 2,000-bed award-winning Student Village on its Mile End campus.
Two-thirds of women not taking folic acid before pregnancy to prevent spina bifida
2014-02-20
ELSE PRESS RELEASES FROM THIS DATE:
Iron deficiency may increase stroke risk through sticky blood
2014-02-20
Scientists at Imperial College London have discovered that iron deficiency may increase stroke risk by making the blood more sticky.
The findings, published in the journal PLOS ONE, could ultimately help with stroke prevention.
Every year, 15 million people worldwide suffer a stroke. Nearly six million die and another five million are left permanently disabled. The most common type, ischaemic stroke, occurs because the blood supply to the brain is interrupted by small clots.
In the last few years, several studies have shown that iron deficiency, which affects around ...
Ants build raft to escape flood, protect queen
2014-02-20
When facing a flood, ants build rafts and use both the buoyancy of the brood and the recovery ability of workers to minimize injury or death, according to a study published in PLOS ONE on February 19, 2014 by Jessica Purcell from University of Lausanne, Switzerland, and colleagues. Furthermore, the queen ant is placed in the middle and protected on all sides by the rafting ants.
When put in harm's way, social animals are often able to work together to enhance the survival and welfare of the group. Ants living on flood plains are known to link to together to create rafts ...
Adding bevacizumab to initital glioblastoma treatment doesn't improve overall survival
2014-02-20
Glioblastoma (GBM) is the most common primary malignant adult brain tumor and, despite treatment advances in recent years, the average survival of patients enrolled in clinical trials is less than 16 months with few patients living beyond five years. GBM tumors are characterized by angiogenesis — the formation of new blood vessels that support tumor growth stimulated by the GBM-produced vascular endothelial growth factor A (VEGF-A). Bevacizumab is a monoclonal antibody that targets VEGF-A production to block the growth of tumor-derived blood vessels. "Clinical trials evaluating ...
Bevacizumab offers no benefit for newly diagnosed glioblastoma, MD Anderson-led study finds
2014-02-20
HOUSTON — The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.
The study appears in the New England Journal of Medicine, and was first presented on the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting by Mark Gilbert, M.D., professor in MD Anderson's Department of Neuro-Oncology.
Glioblastoma is ...
Bevacizumab (Avastin) fails to improve survival for newly diagnosed glioblastoma patients
2014-02-20
BALTIMORE – February 19, 2014. Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.
"We didn't see an improvement in overall survival or a statistically significant increase in progression-free survival, as defined in the context of this trial," says the study's senior author, Minesh P. Mehta, M.B., Ch.B., Professor of Radiation Oncology at the University of Maryland ...
SDSC team develops multi-scale simulation software for chemistry research
2014-02-20
Researchers at the San Diego Supercomputer Center at the University of California, San Diego, have developed software that greatly expands the types of multi-scale QM/MM (mixed quantum and molecular mechanical) simulations of complex chemical systems that scientists can use to design new drugs, better chemicals, or improved enzymes for biofuels production.
A paper outlining the research, titled 'An Extensible Interface for QM/MM Molecular Dynamics Simulations with AMBER' and conducted by members of the Walker Molecular Dynamics Lab (WMD) at SDSC, was featured on the cover ...
Clutter cutter
2014-02-19
WASHINGTON D.C. Feb. 19, 2014 -- Life can be messy at all scales, requiring different organizational strategies -- from cleaning the house, to removing damaged or expired cells from the body to avoid cancer progression.
In a messy house, people use computers to manage paper and photo clutter; companies use computer systems to track their inventory. Now a team of researchers at Vanderbilt University in Nashville, Tenn., is taking a similar approach to cell-molecular inventory control for cancer. They have created computer models, using their programming framework (PySB), ...
Does more stress equal more headaches?
2014-02-19
PHILADELPHIA – A new study provides evidence for what many people who experience headache have long suspected—having more stress in your life leads to more headaches. The study released today will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.
For the study, 5,159 people age 21 to 71 in the general population were surveyed about their stress levels and headaches four times a year for two years. Participants stated how many headaches they had per month and rated their stress level on a scale of zero to ...
Insurance status may influence transfer decisions in trauma cases, Stanford study reveals
2014-02-19
STANFORD, Calif. — Emergency rooms are less likely to transfer critically injured patients to trauma centers if they have health insurance, according to a new study by researchers at the Stanford University School of Medicine.
The counterintuitive finding suggests that insured patients are more at risk for receiving sub-optimal trauma care than uninsured patients are.
Although a majority of severely injured trauma patients are initially taken to trauma centers, at least one-third are taken to non-trauma centers. In these cases, emergency room doctors must assess the ...
HPV vaccination is associated with reduced risk of cervical lesions in Denmark
2014-02-19
A reduced risk of cervical lesions among Danish girls and women at the population level is associated with use of a quadrivalent HPV vaccine after only six years, according to a new study published February 19 in the Journal of the National Cancer Institute.
Two HPV vaccines are currently available and have proven to be highly effective against HPV16/18-associated cervical cancer. One of these vaccines, a quadrivalent vaccine, was licensed in Denmark in 2006, and it was subsequently incorporated into general childhood vaccination programs for girls free of charge and ...